4 Results for "

ROR1-positive cancers

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "ROR1-positive cancers" in MCE Product Catalog:

Cat. No.: HY-160806
CAS No.: 2813268-66-3
Research Areas:  

Cancer

(5-Cl)-Exatecan is a derivative of Exatecan (HY-13631) and a DNA topoisomerase inhibitor. (5-Cl)-Exatecan serves as the cytotoxic payload component in antibody-drug conjugates (ADC) targeting ROR1-positive cancers. (5-Cl)-Exatecan is applicable for the research of ROR1-positive cancers .
loading...
    loading...
Cat. No.: HY-160806A
Research Areas:  

Cancer

(5-Cl)-Exatecan TFA is a derivative of Exatecan (HY-13631) and a DNA topoisomerase inhibitor. (5-Cl)-Exatecan TFA serves as the cytotoxic payload component in antibody-drug conjugates (ADC) targeting ROR1-positive cancers. (5-Cl)-Exatecan TFA is applicable for the research of ROR1-positive cancers .
loading...
    loading...
Cat. No.: HY-164346
CAS No.: 2879227-86-6
Amine-PEG8-Val-Cit-PAB-MMAE is a potent drug-linker conjugate for antibody-drug conjugates (ADCs).Amine-PEG8-Val-Cit-PAB-MMAE consists of the linker amine-PEG8-Vali-Cit-PAB and the payload MMAE (HY-15162), and can be used to synthesize ADCs. Amine-PEG8-Val-Cit-PAB-MMAE can be used for the research of gastric cancer, colon cancer, lung adenocarcinoma .
loading...
    loading...
Cat. No.: HY-187075
CAS No.: 2878440-81-2
Research Areas:  

Cancer

2-MSP-VA-​PAB-MMAE (Compound B-2) is a conjugate of the toxin molecule MMAE (HY-15162) and a linker, which can be used to construct antibody-drug conjugates (ADCs) .
loading...
    loading...